Burning Rock Dx Spotlight: brPROPHET We're excited to highlight the latest advancements in our MRD detection product, brPROPHET, showcased at the recent ASCO conference! Since its market launch on March 1, 2022, brPROPHET has been empowering precision clinical research. Here's what we've achieved so far: 1. Featured in 12 posters at AACR, ASCO, and ESMO 2. Published a paper in Cancer Cell Discover more about brPROPHET and its groundbreaking impact on MRD detection. For detailed information, check the attachment or contact us at PBD@brbiotech.com. Stay tuned for more exciting results coming soon! #MRD #PrecisionMedicine #BurningRockDx
Burning Rock Dx’s Post
More Relevant Posts
-
Assistant Editor, Exploration of Targeted Anti-tumor Therapy (No APC; indexed in PubMed/PMC, Scopus, Google Scholar, DOAJ, CAS et al.)
🎉 Exciting news! Our hot special issue on Molecular Diagnosis and Personalized Therapy of Cancer is gaining more and more attention from researchers. We're thrilled to announce that we're extending the open call for submissions! 👨⚕️ 🔬 Do you have innovative ideas or suggestions on this fascinating topic? We'd love to hear from you! 👀 Share your insights with us and join the discussion. Let's make a difference together! #biomarker, #targetedtherapy, #personalizedcancermedicine, #molecularsignature
To view or add a comment, sign in
-
Enjoying our time at #AACR24! If you are interested in learning more about incorporating autoantibodies in your biomarker strategy, please feel free to reach out to myself or Oncimmune CSO Petra Budde. Oncimmune American Association for Cancer Research
To view or add a comment, sign in
-
-
Explore Our Newest Research Discoveries! Sugar chains unlocking the potential for precise cancer immunotherapies. See More in Details: https://lnkd.in/gBF3bKmQ #trending #cancerjournal #researcher #newpost #medx #reseaprojournals #CANCERRESEARCH #IMMUNOLOGYRESEARCH #NEWSSCIENCENEWS
To view or add a comment, sign in
-
-
Discover how the innovative use of cell-free DNA and methylation patterns is advancing early cancer detection, offering hope for better outcomes. Dive into our latest blog to learn about Cleerly's groundbreaking approach and how it's shaping the future of precision medicine. #EarlyDetection #PrecisionMedicine #InnovationInHealthcare https://loom.ly/71U2mPg
To view or add a comment, sign in
-
🙌 🙌 Welcome to read the #HighlyCitedPaper # A review of "Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges" by Sarah I. Bukhari et al. You can find it at: https://lnkd.in/gDi8UrDF
To view or add a comment, sign in
-
-
In the month of April 2021.... ......at the American Association for Cancer Research (AACR) Annual Meeting Mestastop's Poster No. 2868 revealed this 👇 ........ Feel free to download ⬇ the document and save it for your future reference #metastasis #cancerresearch #cancerdiagnosis #biotechinnovation #posterpresentation #investors #investorshub #drugdevelopment #drugdesign #clinicaltrials #usacompany
To view or add a comment, sign in
-
On September 13th, Medical Device Innovation Consortium (MDIC)'s own Maryellen de Mars will join Justin Zook, Mickey Williams, Girish Putcha, MD, PhD, and Ephrem Chin on a GenomeWeb webinar to talk about our Somatic Reference Sample Initiative! Don't miss this essential presentation on our work to improve the validation and accuracy of #molecular #cancer #diagnostics.
Panel Discussion: The Somatic Reference Sample Initiative to Improve Validation and Accuracy of Molecular Cancer Diagnostics
event.on24.com
To view or add a comment, sign in
-
🧪🔬 Deep dive into cancer diagnostics! When it comes to cancer biomarker testing, preservation is paramount! Explore the significance of ultra-low freezers in safeguarding tissue and fluid samples, enabling accurate assessment of biomarkers. Let's decode the science behind reliable storage. Learn more: https://ow.ly/LSl250PwFab #CancerResearch #Biomarkers #UltraLowFreezers #ColdChain
To view or add a comment, sign in
-
-
From new research reagents to next-gen ADCs and advanced conjugates, aptamers are delivering new solutions in cancer. Learn more about the benefits they offer over traditional affinity ligands and how they can help advance your research in our insight article. https://lnkd.in/ewwpTvZT
To view or add a comment, sign in
-
-
Ones to watch - five upcoming companies on the CAR-T scene CAR-T therapies have big potential to take on blood cancer but also have major drawbacks.... https://lnkd.in/euQMkwwZ #BioTech #science
Ones to watch - five upcoming companies on the CAR-T scene
openexo.com
To view or add a comment, sign in